Overview

Clinical Evaluation of Bacitracin

Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish a concentration of a bacitracin-patch for diagnosing allergic contact dermatitis.
Phase:
Phase 2
Details
Lead Sponsor:
Mekos Laboratories AS
Treatments:
Bacitracin